Home
Mahdi Fallah's picture
Photo:
Mahdi Fallah

Mahdi Fallah

Professor, in Medicine (Epidemiology)
  • E-mailMahdi.Fallah@uib.no
  • Visitor Address
    Alrek helseklynge, blokk D, Årstadveien 17
  • Postal Address
    Postboks 7804
    5020 Bergen

Publications in brief

  • > 80 peer-reviewed original publications (excluding letters and >50 abstracts/posters)
  • Recent papers in top medical journals such as JNCCN, Am J Gastroenterol, PLOS Med (×2), PNAS, Leukemia (×2), Blood, Ann Oncol (×2), Eur Urol, Gastroenterol, JAMA Oncol (×2), BMJ (×2), & JCO [impact factors 9, 10, 10.5,12, 17, 18, 19, 25, 30, 33]
  • PhD monograph, MD thesis, a book, and >20 international presentations
  • Citations: H-index=25; i10-index=50; >2500 times cited
  • Authorship:
    • Corresponding author:                          34 papers +   4 ongoing + >31 abstracts
    • First/co-first(=) principal author:           21 papers +   1 ongoing +   >9 abstracts
    • Last/co-senior(=) responsible author:  20 papers +   3 ongoing + >23 abstracts
    • Second principal author:                       20 papers +   1 ongoing +   >5 abstracts

Selected publications

Publications (Selected out of >80)

IF

Cited

Authorship

25

 

Last

  • Tian Y, Fallah M=(equal contribution), Brenner H, Xu X, Sundquist K, Sundquist J, Kharazmi E=. Calculating starting age for screening in relatives of patients with colorectal cancer based on data from large nationwide datasets. Gastroenterology 2020 159:159–168 (Press released by NCT/DKFZ; Selected as highlight publication of DKFZ; Selected by Editor in chief for US CME).

19

 

Co-senior

Corresponding

(C)

10.5

 

Last

C

  • Ali Khan U, Fallah M=, Tian Y, Sundquist K, Sundquist J, Brenner H, Kharazmi E=. Risk of colorectal cancer in patients with diabetes mellitus: A Swedish nationwide cohort study. PLOS Med 2020 17 (11), e1003431 (Press released by NCT/DKFZ and Reuters News).

10.5

 

Co-senior

C

10

 

Co-senior

C

  • Fallah M, Mukama T, Kharazmi E. Determining the Appropriate risk-adapted screening age for familial breast cancer—Reply. JAMA Oncol 2020 ;6(6):934-935.

25

 

1st

C

  • Tian Y, Kharazmi E=, Sundquist K, Sundquist J, Brenner H, Fallah M=. Family history of colorectal carcinoma in situ as important as family history of invasive colorectal cancer: A nationwide cohort study. J Natl Compr Canc Netw 2021 (In press).

9

 

Last

C

  • Mukama T, Fallah M=, Xu X, Sundquist K, Sundquist J, Brenner H, Kharazmi E=. Risk of invasive breast cancer in relatives of patients with breast carcinoma in situ. BMC Med 2020 18(1):295 (Press released by NCT/DKFZ; Reuters News Report in preparation; IF2019=8)

8

 

Co-senior

C

  • Mukama T, Fallah M=, Tian Y, Sundquist K, Sundquist J, Brenner H, Kharazmi E=. Risk-tailored starting age of breast cancer screening based on reproductive factors: A nationwide cohort study. Eur J Cancer 2020 124:207-213.

7

 

Co-senior

C

  • Xu X, Fallah M=, Tian Y, Sundquist K, Sundquist J, Brenner H, Kharazmi E=. Risk of invasive prostate cancer and prostate cancer-specific death in relatives of patients with prostatic borderline or in situ neoplasia: A nationwide cohort study. Cancer 2020 ;126(19):4371-4378 (Press released by NCT/DKFZ).

6

 

Co-senior

C

  • Mukama T, Fallah M=, Sundquist K, Sundquist J, Brenner H, Kharazmi E=. Breast cancer screening for women with family history of ovarian cancer and other discordant cancers: A nationwide cohort study. Cancer 2021 (doi: 10.1002/cncr.33456)

6

 

Co-senior

C

  • Mukama T, Kharazmi E, Sundquist K, Sundquist J, Brenner H, Fallah M*. Familial risk of breast cancer by dynamic, accumulative, and static definition of family history. Cancer 2020 126:2837-2848.

6

 

Last

C

30

12

Last

C

  • Fallah M=, Kharazmi E=, Pukkala E, Tretli S, Olsen JH, Tryggvadottir L, Sundquist K, Hemminki K. Familial risk of non-Hodgkin lymphoma by sex, relationship, age at diagnosis and histology: a joint study from five Nordic countries. Leukemia. 2016 30(2):373-8 (IF2016: 12).

12

17

1st

C

  • Kharazmi E, Hemminki K, Pukkala E, Sundquist K, Tretli S, Olsen JH, Tryggvadottir L, Fallah M. Cancer risk in relatives of testicular cancer patients by histology type and age at diagnosis: A joint study from five Nordic countries. Eur Urol 2015 68(2):283-9 (selected for CME credit).

18

>30

Last

  • Fallah M=, Kharazmi E=, Pukkala E, Olsen JH, Tryggvadottir L, Sundquist K, Tretli S, Hemminki K. Risk of familial classical Hodgkin lymphoma by relationship, histology, age, and sex: A joint study from five Nordic countries. Blood 2015 126(17):1990-5 (Press released by the American Society of Hematology Clinical News).

17

>30

1st

C

  • Hemminki K, Fallah M, Hemminki A. Collection and use of family history in oncology clinics. J Clin Oncol 2014 32(29):3344-5.

33

 

2nd

  • Fallah M, Liu X, Ji J, Försti A, Sundquist K, Hemminki K. Hodgkin lymphoma after autoimmune diseases by age at diagnosis and histological subtype. Ann Oncol 2014 25(7):1397-404.

18

45

1st

C

  • Fallah M, Liu X, Ji J, Försti A, Sundquist K, Hemminki K. Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study. Ann Oncol 2014 25(10):2025-30.

18

>140

1st

C

  • Fallah M=, Chen T=, Kharazmi E, Ji J, Sundquist K, Hemminki K. Effect of a detailed family history of melanoma on risks for other tumors: A cohort study based on the nationwide Swedish Family-Cancer Database. J Invest Dermatol 2014 134(4):930-6 (IF2015: 7; Nature journals).

7

22

1st

C

  • Fallah M, Pukkala E, Sundquist K, Tretli S, Olsen JH, Tryggvadottir L, Hemminki K. Familial melanoma by histology and age: joint data from five Nordic countries. Eur J Cancer 2014 50(6): 1176-1183.

7

20

1st

C

  • Chen T, Hemminki K, Kharazmi E, Sundquist K, Fallah M. Multiple primary (even in situ) melanomas in a patient pose significant risk to family members. Eur J Cancer 2014 50(15):2659-67.

7

25

Last

  • Fallah M, Pukkala E, Tryggvadottir L, Olsen JH, Tretli S, Sundquist K, Hemminki K. Risk of thyroid cancer in first-degree relatives of patients with non-medullary thyroid cancer by histology type and age at diagnosis: a joint study from five Nordic countries. J Med Genet 2013 50(6):373-82 (IF2010: 7; BMJ journals).

7

>40

1st

C

  • Roudgari H, Hemminki K, Brandt A, Sundquist J, Fallah M. Prostate cancer risk assessment model: A scoring model based on the Swedish Family-Cancer Database. J Med Genet 2012 49(5):345-352 (IF2010: 7; BMJ journals).

7

12

Last

C

  • Kharazmi E, Fallah M, Sundquist K, Hemminki K. Familial risk of early and late onset cancer: nationwide prospective cohort study. BMJ 2012 345:e8076 (Selected for BMJ press release on 21 Dec 2012: Cancer diagnosis later in life poses significant risk to offspring).

30

65

2nd

  • Fallah M, Kharazmi E, Thomsen H, Sundquist J, Hemminki K. Determinants of unfavorable presentation of primary cutaneous melanoma. J Am Acad Dermatol 2011 65(1):e5–6.

8

 

1st

C

  • Fallah M, Kharazmi E. Substantial under-estimation in cancer incidence estimates for developing countries due to under-ascertainment in elderly cancer cases. Cancer Letters 2008 264(2):250–55.

7

12

1st

C

 

 

 

PhD Monograph, MD Thesis, and Book,

 

  • PhD monograph: Fallah M. Cancer Incidence in Five Provinces of Iran, 1996–2000. Acta Universitatis Tamperensis, Faculty of Medicine at University of Tampere, Tampere, Finland 2007:1–193(>30 times cited).
  • MD thesis: Fallah M. Young couples’ attitude towards gender and desired number of children. Department of Community Medicine, Isfahan University of Medical Sciences, Iran, 1999.
  • Book: Fallah M. Girl or boy? A Scientific Method of Sex Preselection. Arghanoon Publication, Tehran, Iran, 1998, reprinted in 2000, 2002, and 2006, pp 1–384.

 

 

Risk-adapted colorectal cancer screening

Risk-adapted breast cancer screening

Risk-adapted prostate cancer screening